An intra-individual randomised controlled study to evaluate the efficacy and tolerance of the product RV4421 A BS0042 in association with a moderately potent topical corticosteroid in adults with atopic dermatitis
An intra-individual randomised controlled study to evaluate the efficacy and tolerance of the product RV4421 A BS0042 in association with a moderately potent topical corticosteroid in adults with atopic dermatitis
An intra-individual randomised controlled study to evaluate the efficacy and tolerance of the product RV4421 A BS0042 in association with a moderately potent topical corticosteroid in adults with atopic dermatitis
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
65
Ans
Genre
Tous
Aire thérapeutique :
Dermatologie
Maladie :
Dermatite atopique
Traitement :
Rv4421abs0042
Phase :
Phase II
Date de début de l'étude :
01 Octobre 2014
End date :
09 Juillet 2015
Identifiant de l'essai :
RV4421A 2013147
Identifiant EudraCT/CTIS :
2014-002194-10
Envoyer par email